Surgilight, ex-chairman, sued by SEC (US Securities and Exchange Commission) over stock manipulation
This article was originally published in Clinica
The US Securities and Exchange Commission (SEC) is suing laser eye surgery company Surgilight, together with its former chairman and his wife, accusing them of a stock manipulation scheme, allowing them to reap $1.7 million in illicit proceeds.
You may also be interested in...
Business development leaders and venture capital investors spoke at Biocom’s annual partnering conference about what they are seeking in relationships with entrepreneurs and start-ups.
Mylan’s full year 2019 earnings report was its last as an independent company, so the focus was on the coming merger with Pfizer’s Upjohn and growth prospects for the new company, Viatris.
Colgate Zero toothpastes and mouthwashes promote what’s missing; Tom’s of Maine natural personal care expands with prebiotic toothpaste, deodorant and hand soap; Gaia adds hemp to its herbs; and Church & Dwight goes environmentally friendly with VitaFusion Goodness supplements, adds CBD versions to line, too.